Project Grant 1534798

Federal Cooperative Agreement Summary Award Details: Iiam Corporation received a $1.25 million Cooperative Agreement from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084), effective July 15, 2025, with completion targeted for June 30, 2027. The project will be performed in San Francisco, California. Products and Services: This Small Business Innovation Research (SBIR) Phase II project delivers a Natural Language Processing (NLP)-driven...

Molecular Intelligence LLC received a $435,882 Phase I Small Business Innovation Research (SBIR) Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded September 1, 2025, with completion targeted for February 28, 2027. The company will develop advanced artificial intelligence-enabled software tools for structure and ligand modeling capable of accurately modeling drug-receptor interactions...

Mindtrace Technologies, Inc. received a $1.2M Cooperative Agreement award from the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084), effective May 15, 2025, through April 30, 2027. The company is developing a novel cognitive dashboard software platform designed to support clinical decision-making in neurosurgery by integrating multiple data sources including behavioral assessments, functional brain mapping protocols, and...

This $275,000 Small Business Innovation Research (SBIR) Phase I award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) supports Prhobe Inc.'s development of an innovative logistics tracking system. The project aims to revolutionize logistics and transport management by providing real-time visibility at the serial number level through the integration of wireless technologies including RFID, UWB, and cellular. The system will attach to...

Federal Cooperative Agreement Summary Award: NSF SBIR Phase II: nCapsule Personalized Cancer Screening for Colorectal Cancer Treatment Regimens Funding Agency: National Science Foundation (NSF) Technology, Innovation, and Partnerships (TIP) Program (CFDA 47.084) Awardee: Encapsulate Inc., Farmington, Connecticut Award Amount: $1,213,619 | Award Date: June 15, 2025 | Completion Date: May 31, 2027 Encapsulate Inc. is developing an integrated precision oncology platform that combines microfluidics,...

Federal Grant Award Summary Translucence Biosystems, Inc. received a $1,400,651 Project Grant from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), awarded September 20, 2025, with a completion date of May 31, 2027. The company is developing and refining a proprietary Vasculature Subtraction Parenchymal Quantification (VSPQ) workflow integrated into its 3D brain imaging and analysis platform. This software tool addresses critical...

Federal Grant Award Summary Across AI, Inc. received a $305,000 Phase I Small Business Innovation Research (SBIR) award from the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084), effective July 1, 2025 through June 30, 2026. The company will develop a novel artificial intelligence (AI) framework that combines algorithmic logical reasoning with machine learning models to enhance the analysis of unstructured data in enterprise...

Federal Cooperative Agreement Summary Abstractive Health, Inc. received a $1.25 million Small Business Innovation Research (SBIR) Phase II Cooperative Agreement from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084), effective July 1, 2025, through June 30, 2027. The awardee will develop and refine a machine learning-enabled software tool that leverages natural language processing (NLP) to automatically generate clinically relevant...

This $275,000 Small Business Innovation Research (SBIR) Phase I award from the National Science Foundation's (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) program aims to develop a suite of software that automatically routes building services systems through 3D obstructed space to achieve near-optimal, clash-free solutions. The project involves developing a highly efficient 3D modeling environment using "low-resolution surface tessellation" to minimize data storage and...

The U.S. National Science Foundation (NSF) awarded a $303,864 Phase I Small Business Innovation Research (SBIR) grant under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program to Core Biotherapeutics, Inc. (UEI N9FGZ15RQGJ4) located in Ladera Ranch, CA. The project aims to develop a platform for discovering therapeutic drug candidates that can modulate molecular networks driving diseases, with the potential to produce disease-modifying effects for neurodegenerative...